Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Ohio Board of Pharmacy urges budget support for OARS, warns of counterfeit medications
Summary
Ohio Board of Pharmacy Executive Director Steve Shurholdt told the House Health Committee the board needs funding in the governor—s executive budget (House Bill 96) to sustain licensing operations and OARS, and highlighted a rise in counterfeit and illegally imported medications that harmed patients.
Steve Shurholdt, executive director of the Ohio Board of Pharmacy, told the Ohio House Health Committee the board—s budget request in House Bill 96 does not use GRF funds and is aimed at sustaining licensing and public-safety functions.
Shurholdt said the board employs 92 staff who oversee licensure for more than 93,000 pharmacists, interns, technicians and licensed locations. He said staffing and process improvements have shortened pharmacy technician processing to "less than 3 business days," which he described as necessary to keep the state "open for business."
Shurholdt warned the committee about an increase in counterfeit and substandard medications, citing federal and state seizures. "Customs and Border Patrol in Cincinnati reported at least 11 seizures of counterfeit Ozempic in 2024," he said, and added that the board,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
